A Study of HR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark.
Clinical trial NCT06307457 · COMPLETED
Trial details
- NCT number
- NCT06307457
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-03-06
- Primary completion
- 2024-04-19
- Enrollment
- 604
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.